CELU: Celularity Corp O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Onkologiyada yo'ldosh hujayralari terapiyasining muvaffaqiyatiga istiqbollari bog'liq bo'lgan Celularity Inc. (CELU) kompaniyasiga investitsiya kiritishga arziydimi? Foyda o'sish sur'atlariga nisbatan vaznli P/E ko'rsatkichi javobni beradi, bunda 0.00 qiymati ushbu darajani xarakterlaydi. Biznes klinik sinovlarni o'tkazish uchun tashqi provayderlarga tayanadi, shu bilan birga mijozlar bazasini kengaytirish uchun regenerativ va estetik tibbiyot nishalariga kirib bormoqda.
Celularity Inc. (CELU) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Celularity Inc.|CELU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi celularity.com|CELU - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Celularity Corp|CELU - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Celularity|Shoshilinch likvidlik celularity.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CELU - Kompaniyaning sof foydasi|Kutilayotgan foyda Celularity Inc.|CELU - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori celularity.com|CELU - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Celularity Corp|CELU - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Celularity|CELU - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi celularity.com|CELU - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Celularity Inc.
Kompaniyaning umumiy tahlili:CELU - Celularity Inc
Kapital menejeri aktivning kengayishiga nisbatan ob'ektiv baholashini talab qiladi. Ushbu metrika P/E koeffitsientini foyda o'sish sur'atlari bilan solishtiradi, bunda birdan past qiymat aktivning qadrsizlanganligidan dalolat beradi. PEG koeffitsienti grafigini tahlil qilish orqali investor bozor narxining adolatli ekanligini aniqlaydi. Bu holat Celularity Inc. (CELU) uchun juda muhimdir, chunki klinik bosqichlardagi bemorlar bazasining barqarorligiga qaramay, likvidlik tanqisligi sheriklik aloqalarini cheklamoqda.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|Pharvaris Pharma (PHVS) - Narx-foyda va o‘sish multiplikatori|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda tourmalinebio.com (TRML)|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|PEG multiplikatori Upstream Pharma (UPB)|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Biopharma Inc ZBIO|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|Gossamer Bio - PEG multiplikatori|KALV - PEG multiplikatori|Septerna Corp (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc.) - PEG multiplikatori|rigel.com (RIGL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori ANAB (AnaptysBio)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ATXS|enGene Bio - Narx-foyda va o‘sish multiplikatori|rapt.com (RAPT) - O‘sish sur’atiga tuzatilgan narx-foyda|JBIO: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|KYTX: PEG multiplikatori|TLSA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VTYX (Ventyx Biosciences, Inc)|PEG multiplikatori THTX|Narx-foyda va o‘sish multiplikatori avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Agenus, Inc. (AGEN)|Climb Bio, Inc. - PEG multiplikatori|zurabio.com (ZURA) - Narx-foyda va o‘sish multiplikatori|ATYR: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Adagene Inc. (ADAG)|Narxning foydaga va o‘sish sur’atiga nisbati ImageneBio|Narxning foydaga va o‘sish sur’atiga nisbati STTK|Narx-foyda va o‘sish multiplikatori EQ (Equillium, Inc.)|PEG multiplikatori connectbiopharm.com (CNTB)|Narxning foydaga va o‘sish sur’atiga nisbati Immunic IMUX|ATRA (Atara Biotherapeutics, Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|InflaRx GmbH - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XFOR (X4 Pharmaceuticals Inc.)|ACET: PEG multiplikatori|INmune Bio Corporation (INMB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|Narx-foyda va o‘sish multiplikatori Akari Therapeutics PLC AKTX|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|PEG multiplikatori Q32 Bio Inc QTTB|GOVX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (edesabiotech.com)|IBIO: PEG multiplikatori|CARM - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|Narx-foyda va o‘sish multiplikatori aptevotherapeutics.com APVO|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Aditxt Inc. ADTX|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|XRTX (XORTX Corp) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|HIND: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revbiosciences.com (REVB)|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|PEG multiplikatori CALI|AFMD - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOKIPA Pharma, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|IGMS: Narx-foyda va o‘sish multiplikatori|ITOS - PEG multiplikatori|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|TCBP (TC BioPharm Ltd) - Narxning foydaga va o‘sish sur’atiga nisbati|THRD (Third Harmonic Bio) - PEG multiplikatori
